ReviewAnnals of translational medicine2022

Emerging therapies for non-small cell lung cancer harboring EGFR exon 20 insertion mutations: narrative review.

Naohiro Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.